Chemocentryx Inc. · NASDAQ:CCXI
Empyrean Capital Partners, LP reported a 7.52% stake in Chemocentryx Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Empyrean Capital Partners, LP reported a 7.52% stake in Chemocentryx Inc., 3,150,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 7.52%
- Shares
- 3,150,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empyrean Capital Partners, LP | 7.52% | 3,150,000 |
| Meron Amos | 7.52% | 3,150,000 |
Source
Related
- Chemocentryx Inc.
- Empyrean Capital Partners, LP
- Chemocentryx Inc. shareholders
- Schedule 13G/A · MMCAP International Inc. SPC · Aug 14, 2026
- Schedule 13G/A · Fort Baker Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Magnetar Financial LLC · Aug 13, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 31, 2026